Pricing Log in Create free account

electroCore, Inc. (ECOR) vs Sera Prognostics, Inc. (SERA)

electroCore, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. electroCore, Inc. and Sera Prognostics, Inc. are of similar size ($82.1M and $79.3M). electroCore, Inc. grew revenue faster over the last twelve months: 27.3% against 1.05%. electroCore, Inc. has the higher net margin (−33.5% vs −34,866.7%) and the higher return on invested capital (−193.1% vs −278.6%). Across the 17 metrics below, electroCore, Inc. leads on 14 and Sera Prognostics, Inc. on 3.

Valuation

Metric ECOR SERA Medical Devices median
P/E n/m n/m 25.58
P/S 2.14 1,100.45 2.54
P/B n/m 2.01 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 2.06 641.21 2.72
Earnings yield (16.07%) (32.21%) (12.82%)
Free cash flow yield (13.41%) (27.81%) (8.18%)

Profitability

Metric ECOR SERA Medical Devices median
Gross margin 87.67% 0.00% 57.76%
Operating margin (33.15%) (38,755.21%) (15.07%)
Net margin (33.46%) (34,866.67%) (14.45%)
Free cash flow margin (28.70%) (30,198.96%) (3.88%)
Return on equity 709.52% (49.73%) (10.35%)
Return on assets (65.70%) (35.59%) (17.26%)
Return on invested capital (193.07%) (278.58%) (5.27%)

Growth

Metric ECOR SERA Medical Devices median
Revenue growth (TTM) 27.26% 1.05% 10.41%
EPS growth (last fiscal year) (3.77%) 32.32% 28.17%
Revenue growth, 5-year CAGR 55.74% 26.51% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ECOR SERA Medical Devices median
Debt to equity (2.62) 0.00 0.04
Current ratio 1.34 1.88 2.74
Net debt to EBITDA 0.40 1.10 0.54

Dividend

Metric ECOR SERA Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric ECOR SERA Medical Devices median
Market cap 79.34m 82.05m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack